Michele Reni
Impact in
Papers in
- Co-authors
- Andrés J.M. FerreriElena MazzaCharles J. VechtAlba A. BrandesGianpaolo BalzanoEileen M. O’ReillyStefano CeredaValerio Di Carlo
- Journals
- Journal of Clinical Oncology (41 papers)Annals of Oncology (38 papers)Critical Reviews in Oncology/Hematology (15 papers)Radiotherapy and Oncology (13 papers)International Journal of Radiation Oncology*Biology*Physics (12 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Michele Reni
306 papers receiving 11.2k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Genetics 2.9k
- Oncology 6.1k
- Cancer Research 2.5k
- Neurology 2.1k
- Pathology and Forensic Medicine 1.7k
Countries citing papers authored by Michele Reni
This map shows the geographic impact of Michele Reni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Reni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Reni more than expected).
Fields of papers citing papers by Michele Reni
This network shows the impact of papers produced by Michele Reni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Reni. The network helps show where Michele Reni may publish in the future.
Co-authors
The 25 scholars most cited alongside Michele Reni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 120 | |
| 11 | 2022 | 9 | |
| 12 | 2020 | 14 | |
| 13 | Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer Hit paper breakdown → | 2019 | 1468 |
| 14 | 2019 | 33 | |
| 15 | nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial | 2017 | 2 |
| 16 | 2016 | 124 | |
| 17 | 2015 | 140 | |
| 18 | 2013 | 11 | |
| 19 | 2008 | 142 | |
| 20 | Questions and answers in the management of primary central nervous system and ocular lymphomas. | 2003 | 3 |
About Michele Reni
Michele Reni is a scholar working on Oncology, Genetics, Cancer Research, Pulmonary and Respiratory Medicine and Neurology, having authored 321 papers that have together received 11.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (185 papers), Cancer Genomics and Diagnostics (87 papers), Glioma Diagnosis and Treatment (68 papers), Neuroendocrine Tumor Research Advances (51 papers), Renal cell carcinoma treatment (44 papers), CNS Lymphoma Diagnosis and Treatment (38 papers), Lymphoma Diagnosis and Treatment (31 papers) and Brain Metastases and Treatment (22 papers). The work is most often cited by research in Genetics (2.9k citations), Oncology (6.1k citations), Cancer Research (2.5k citations), Neurology (2.1k citations) and Pathology and Forensic Medicine (1.7k citations). Michele Reni has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Andrés J.M. Ferreri, Elena Mazza, Charles J. Vecht, Alba A. Brandes, Gianpaolo Balzano, Eileen M. O’Reilly, Stefano Cereda, Valerio Di Carlo, Teresa Macarulla and Claudio Doglioni. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Critical Reviews in Oncology/Hematology, Radiotherapy and Oncology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.